杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/05/16 | 2,452 | 2,460 | 2,438 | 2,454 | +15 | +0.6% | 158,700 |
2017/05/15 | 2,435 | 2,453 | 2,424 | 2,439 | +4 | +0.2% | 127,600 |
2017/05/12 | 2,422 | 2,462 | 2,412 | 2,435 | +11 | +0.5% | 289,200 |
2017/05/11 | 2,421 | 2,438 | 2,400 | 2,424 | -24 | -1% | 163,300 |
2017/05/10 | 2,451 | 2,458 | 2,425 | 2,448 | +10 | +0.4% | 188,500 |
2017/05/09 | 2,411 | 2,443 | 2,411 | 2,438 | +12 | +0.5% | 192,300 |
2017/05/08 | 2,405 | 2,435 | 2,391 | 2,426 | +55 | +2.3% | 255,100 |
2017/05/02 | 2,360 | 2,381 | 2,348 | 2,371 | +23 | +1% | 134,000 |
2017/05/01 | 2,327 | 2,357 | 2,300 | 2,348 | +16 | +0.7% | 145,600 |
2017/04/28 | 2,307 | 2,339 | 2,307 | 2,332 | +31 | +1.3% | 157,600 |
2017/04/27 | 2,314 | 2,314 | 2,291 | 2,301 | -14 | -0.6% | 137,600 |
2017/04/26 | 2,326 | 2,332 | 2,304 | 2,315 | +11 | +0.5% | 111,500 |
2017/04/25 | 2,302 | 2,308 | 2,274 | 2,304 | -5 | -0.2% | 236,400 |
2017/04/24 | 2,293 | 2,319 | 2,279 | 2,309 | +44 | +1.9% | 130,900 |
2017/04/21 | 2,270 | 2,275 | 2,251 | 2,265 | +17 | +0.8% | 138,300 |
2017/04/20 | 2,255 | 2,270 | 2,244 | 2,248 | -21 | -0.9% | 139,500 |
2017/04/19 | 2,252 | 2,281 | 2,251 | 2,269 | +6 | +0.3% | 273,300 |
2017/04/18 | 2,287 | 2,287 | 2,255 | 2,263 | -25 | -1.1% | 288,000 |
2017/04/17 | 2,290 | 2,291 | 2,270 | 2,288 | +10 | +0.4% | 147,200 |
2017/04/14 | 2,310 | 2,313 | 2,274 | 2,278 | -35 | -1.5% | 78,000 |
2017/04/13 | 2,303 | 2,325 | 2,290 | 2,313 | -2 | -0.1% | 162,300 |
2017/04/12 | 2,309 | 2,320 | 2,294 | 2,315 | -17 | -0.7% | 113,500 |
2017/04/11 | 2,316 | 2,339 | 2,310 | 2,332 | ±0 | ±0% | 136,100 |
2017/04/10 | 2,355 | 2,365 | 2,318 | 2,332 | +2 | +0.1% | 155,200 |
2017/04/07 | 2,330 | 2,354 | 2,318 | 2,330 | +13 | +0.6% | 240,300 |
2017/04/06 | 2,374 | 2,389 | 2,301 | 2,317 | -57 | -2.4% | 255,000 |
2017/04/05 | 2,383 | 2,406 | 2,364 | 2,374 | -14 | -0.6% | 257,200 |
2017/04/04 | 2,368 | 2,408 | 2,362 | 2,388 | -1 | ±0% | 231,400 |
2017/04/03 | 2,352 | 2,408 | 2,352 | 2,389 | +38 | +1.6% | 187,000 |
2017/03/31 | 2,412 | 2,412 | 2,351 | 2,351 | -30 | -1.3% | 153,800 |
2017/03/30 | 2,409 | 2,426 | 2,381 | 2,381 | -26 | -1.1% | 149,900 |
2017/03/29 | 2,417 | 2,417 | 2,390 | 2,407 | -26 | -1.1% | 129,500 |
2017/03/28 | 2,424 | 2,440 | 2,412 | 2,433 | +40 | +1.7% | 157,900 |
2017/03/27 | 2,380 | 2,417 | 2,380 | 2,393 | -21 | -0.9% | 116,900 |
2017/03/24 | 2,384 | 2,420 | 2,370 | 2,414 | +15 | +0.6% | 123,200 |
2017/03/23 | 2,397 | 2,406 | 2,378 | 2,399 | +5 | +0.2% | 97,400 |
2017/03/22 | 2,392 | 2,418 | 2,391 | 2,394 | -45 | -1.8% | 103,300 |
2017/03/21 | 2,425 | 2,452 | 2,425 | 2,439 | +14 | +0.6% | 137,400 |
2017/03/17 | 2,421 | 2,437 | 2,403 | 2,425 | -16 | -0.7% | 231,600 |
2017/03/16 | 2,442 | 2,458 | 2,430 | 2,441 | -23 | -0.9% | 129,200 |
2017/03/15 | 2,444 | 2,474 | 2,431 | 2,464 | +1 | ±0% | 97,000 |
2017/03/14 | 2,472 | 2,503 | 2,462 | 2,463 | ±0 | ±0% | 119,400 |
2017/03/13 | 2,449 | 2,473 | 2,446 | 2,463 | +14 | +0.6% | 126,900 |
2017/03/10 | 2,419 | 2,455 | 2,419 | 2,449 | +66 | +2.8% | 151,700 |
2017/03/09 | 2,416 | 2,421 | 2,376 | 2,383 | -6 | -0.3% | 124,200 |
2017/03/08 | 2,387 | 2,389 | 2,356 | 2,389 | -20 | -0.8% | 218,200 |
2017/03/07 | 2,402 | 2,415 | 2,397 | 2,409 | +9 | +0.4% | 93,900 |
2017/03/06 | 2,397 | 2,408 | 2,384 | 2,400 | -34 | -1.4% | 124,100 |
2017/03/03 | 2,427 | 2,452 | 2,427 | 2,434 | -5 | -0.2% | 89,200 |
2017/03/02 | 2,464 | 2,480 | 2,437 | 2,439 | +11 | +0.5% | 197,900 |
1951~
2000
件表示中 / 3696件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 145,800円 | +8.8% | +99.9% | 3.57% | 9.31倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 217,200円 | +3.1% | -6.5% | 2.21% | 10.08倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.59倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 219,500円 | +0.4% | -8.4% | 2.41% | 28.18倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 85,200円 | +20.3% | - | 0.00% | 150.26倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム